Please assess the completion status of the following clinical trial:

Trial Title: Targeting Self-regulatory Deficits Through Cognitive Remediation Intervention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Meet current DSM-5 criteria for an alcohol, stimulant, cannabis, or opioid use disorder.~* Are sufficiently stable for 4 weeks of outpatient treatment.~* Are willing to provide locator information.~* Are fluent in English and have a 4th grader or higher reading level~Exclusion Criteria:~* Meet DSM-5 criteria for a bipolar or schizophrenic disorder.~* Who have a legal case pending such that incarceration during the 4-week protocol is likely.~* Are physically dependent on alcohol, opioids or benzodiazepines or who report recent PCP use.~* Have a baseline Shipley estimated IQ less than 70~* Have 3 or more head injuries with loss of consciousness for over 30 minutes or lasting effects~* Have a history of chronic illness or neurological disorders (e.g., epilepsy or stroke) that would complicate evaluation of effects of cognitive training

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- TAU plus Cognitive Remediation Program (Type: EXPERIMENTAL): Treatment normally received at this clinic that generally includes individual or group sessions and regular urine monitoring PLUS computerized games that focus on learning and decision making.
- TAU plus Control Tasks (Type: PLACEBO_COMPARATOR): Treatment normally received at this clinic that generally includes individual or group sessions and regular urine monitoring PLUS a series of computerized word games.

Based on this trial design, predict the completion outcome and termination type (if applicable).